Combination effect of melatonin and dexamethasone on liver ischemia/reperfusion injury

Bratislava Medical Journal

Volumn 117, Issue 1, 2016, Pages 47-53

  Taghizadieh, M ^a   Hajipour, B ^b   Ahmadi Asl, N ^c   Khodadadi, A ^a   Somi, M H ^c   Banei, M ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dexamethasone; Ischemia reperfusion; Liver; Melatonin; Rat

Indexed keywords

DEXAMETHASONE; MELATONIN; PROTECTIVE AGENT;

ANIMAL; APOPTOSIS; CHEMISTRY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; MALE; RAT; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; APOPTOSIS; DEXAMETHASONE; DRUG-INDUCED LIVER INJURY; MALE; MELATONIN; PROTECTIVE AGENTS; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 85014841597     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2016_010     Document Type: Article

References (58)

1. Pringle JH. Notes on the arrest of hepatic hem orrhage due to trauma. Ann Surg 1908; 48: 541-549.
2. Pannen BH. New insights into the regulation of hepatic blood flow after ischemia and reperfusion. Anesth Analg 2002; 94: 1448-1457.
3. Ramalho FS, Fernandez-Monteiro I, Rosello-Catafau J, Peralta C. Hepatic microcirculatory failure. Acta Cir Bras 2006; 21: 48-53.
4. Jaeschke H. Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatol 1998; 21: 402-408.
5. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 1990; 85: 1936-1943.
6. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
7. Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun 1991; 15: 277-284.
8. Jaeschke H, Farhood A. Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol Med 2002; 33: 210-219.
9. Gonzalez-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest 1993; 91: 456-464.
10. Polat KY, Aydinli B, Polat O, Aydin U, Yazici P, Ozturk G, Gundogdu C, Kiziltunc A. The protective effect of aprotinin and alpha-tocopherol on ischemia-reperfusion injury of the rat liver. Transplant Proc 2008; 40: 63-68.
11. Pei Z, Pang SF, Cheung RT. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. Stroke. 2003; 34: 770-775.
12. Othman AI, El-Missiry MA, Amer MA, Arafa M. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats. Life Sci 2008; 83: 563-568.
13. Kedziora-Kornatowska K, Szewczyk-Golec K, Czuczejko J, Pawluk H, van Marke de Lumen K, Kozakiewicz M, Bartosz G, Kedziora J. Antioxidative effects of melatonin administration in elderly primary essential hypertension patients. J Pineal Res. 2008; 45: 312-317.
14. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, Bonior J, Szklarczyk J, Kot M, Konturek SJ, Pawlik WW. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58: 65-80.
15. Vairetti M, Ferrigno A, Bertone R, Rizzo V, Richelmi P, Bertè F, Reiter RJ, Freitas I. Exogenous melatonin enhances bile flow and ATP levels after cold storage and reperfusion in rat liver: implications for liver transplantation. J Pineal Res 2005; 38: 223-230.
16. Baykara B, Tekmen I, Pekcetin C, Ulukus C, Tuncel P, Sagol O, Ormen M, Ozogul C. The protective effects of carnosine and melatonin in ischemia-reperfusion injury in the rat liver. Acta Histochem 2009; 111: 42-51.
17. Odermatt A, Gumy C. Glucocorticoid and mineralocorticoid action: why should we consider influences by environmental chemicals? Biochem Pharmacol 2008; 76: 1184-1193.
18. Simons SS Jr. What goes on behind closed doors: physiological versus pharmacological steroid hormone actions. Bioessays 2008; 30: 744-756.
19. Morariu AM, Loef BG, Aarts LP, Rietman GW, Rakhorst G, van Oeveren W, Epema AH. Dexamethasone: benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting: a study on myocardial, pulmonary, renal, intestinal, and hepatic injury. Chest 2005; 128: 2677-2687.
20. Dibazar F, Hajipour B, Hosseinian MM, Hemmati MR, Ghandiha A. Simvastatin decreases hepatic ischaemia/reperfusion-induced liver and lung injury in rats. Folia Morphol 2008; 67: 231-235.
21. Paoletti F, Aldinucci D, Mocali A, Caparrini A. A sensitive spectrophotometric method for the determination of superoxide dismutase activity in tissue extracts. Anal Biochem 1986; 154: 536-541.
22. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
23. Mihara M, Uchiyama M. Effects of antioxidants on the TBA reaction of various rat liver homogenates, Biochem Med 1983; 30: 131.
24. Kirimlioglu H, Ecevit A, Yilmaz S, Kirimlioglu V, Karabulut AB. Effect of resveratrol and melatonin on oxidative stress enzymes, regeneration, and hepatocyte ultrastructure in rats subjected to 70% partial hepatectomy. Transplant Proc 2008; 40: 285-289.
25. Lee KJ, Choi JH, Khanal T, Hwang YP, Chung YC, Jeong HG. Protective effect of caffeic acid phenethyl ester against carbon tetrachlorideinduced hepatotoxicity in mice. Toxicology 2008; 248: 18-24.
26. Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X. Splenectomy ameliorates acute multiple organ damage induced by liver warm ischemia reperfusion in rats. Surgery 2007; 141: 32-40.
27. Zwacka RM, Zhang Y, Halldorson J, Schlossberg H, Dudus L, Engelhardt JF. CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest 1997; 100: 279.
28. Lee WY, Lee JS, Lee SM. Protective effects of combined ischemic preconditioning and ascorbic acid on mitochondrial injury in hepatic ischemia/reperfusion. J Surg Res 2007; 142: 45-52.
29. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850.
30. Soeda J, Miyagawa S, Sano K, Masumoto J, Taniguchi S, Kawasaki S. Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver. Am J Physiol Gastrointest Liver Physiol 2001; 281: 1115-1123.
31. Dünschede F, Erbes K, Kircher A, Westermann S, Seifert J, Schad A, Oliver K, Kiemer AK, Theodor J. Reduction of ischemia reperfusion injury after liver resection and hepatic inflow occlusion by a-lipoic acid in humans. World J Gastroenterol 2006 14; 12: 6812-6817.
32. Rutkowski T, Plewka A, Kaminski M. Study on ischemic/reperfusion damage to the liver: Hitherto existing successes and defeats. Acta Polo Toxicol 2000; 8: 1-15
33. Henry DC, Wenshi G, Sadayuki N. Evidence that free radicals are involved in graft failure following orthotopic liver transplantation in the rat-an electron paramagnetic resonance spin trapping study. Transplantation 1992; 54: 199-204.
34. Burke A, FitzGerald GA, Lucey MR. A prospective analysis of oxidative stress and liver transplantation. Transplantation 2002; 74: 217-221.
35. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JF. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation 1985; 40: 584-590.
36. Omar R, Nomikos I, Piccorelli G. Prevention of postischemic lipid peroxidation and liver cell injury by iron chelation. Gut 1989; 30: 510.
37. Yuan GJ, Ma JC, Gong ZJ, Sun XM, Zheng SH, Li X. Modulation of liver oxidant-antioxidant system by ischemic preconditioning during ischemia/reperfusion injury in rats. World J Gastroenterol 2005; 11: 1825-1828.
38. Minor T, Isselhard W, Yamamoto Y, Obara M, Saad S. The effects of allopurinol and SOD on lipid peroxidation and energy metabolism in the liver after ischemia in an aerobic/anaerobic persufflation. Surg Today 1993; 23: 728.
39. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Seglutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994; 17: 235-248.
40. Zhang XP, Xu HM, Jiang YY, Yu S, Cai Y, Lu B, Xie Q, Ju TF. Influence of dexamethasone on mesenteric lymph node of rats with severe acute pancreatitis. World J Gastroenterol 2008; 14: 3511-3517.
41. Kaçmaz A, User EY, Sehirli AO, Tilki M, Ozkan S, Sener G. Protective effect of melatonin against ischemia/reperfusion-induced oxidative remote organ injury in the rat. Surg Today 2005; 35: 744-750.
42. Ozturk H, Eken H, Ozturk H, Buyukbayram H. Effects of dexamethasone on small bowel and kidney oxidative stress and histological alterations in bile duct-ligated rats. Pediatr Surg Int 2006; 22: 709-718.
43. Oshima Y, Kuroda Y, Kunishige M, Matsumoto T, Mitsui T. Oxidative stress-associated mitochondrial dysfunction in corticosteroid-treated muscle cells. Muscle Nerve 2004; 30: 49-54.
44. Casey JP, Short BL, Rink RD. The effect of methylpre-dnisolone on hepatic oxygen supply and plasma lactate and glucose in endotoxemia. Circ Shock 1979; 6: 245-253.
45. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, Marty J, Farges O. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
46. Usami M, Furuchi K, Shiroiwa H, Saitoh Y. Effect of repeated portal triad cross-clamping during partial hepatectomy on hepatic regeneration in normal and cirrhotic rats. J Surg Res 1994; 57: 541.
47. Helewski KJ, Kowalczyk-Ziomek GI, Konecki J. Neutrophils' contribution to ischaemia and reperfusion injury in liver. Wiad Lek 2007; 60: 47-52.
48. Rudiger HA, Graf R, Clavien PA. Liver ischemia: apoptosis as a central mechanism of injury. J Invest Surg 2003; 16: 149-159.
49. Hatano E, Bradham CA, Stark A, Iimuro Y, Lemasters JJ, Brenner DA. The mitochondrial permeability transition augements Fas-induced apoptosis in mouse hepatocytes. J Biol Chem 2000; 275: 11814-11823.
50. Faubion WA, Gore GJ. Death receptors in liver biology and pathobiology. Hepatology 1999; 29: 1-4.
51. Ma M, Ma ZH. Effect of tumor necrosis factor-alpha in rats with hepatic ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int 2008; 7: 296-299.
52. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 1998; 274: 577-595.
53. Arras M, Höche A, Bohle R, Eckert P, Riedel W, Schaper J. Tumor necrosis factor in macrophages of heart, liver, kidney and in the pituitary gland. Cell Tissue Res 1996; 256: 39-49.
54. Pevni D, Frolkis I, Shapira I, Schwartz D, Schwartz I, Chernichovski T, Nesher N, Uretzky G. Cardioplegic ischemia or reperfusion: which is a main trigger for tumor necrosis factor production? Int J Cardiol 2008; 127: 186-191.
55. Yang YL, Li JP, Xu XP, Dou KF, Yue SQ, Li KZ. Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats. World J Gastroenterol 2004; 10: 3161-3164.
56. Kurcer Z, Oguz E, Ozbilge H, Baba F, Aksoy N, Celik H, Cakir H, Gezen MR. Melatonin protects from ischemia/reperfusion-induced renal injury in rats: this effect is not mediated by proinflammatory cytokines. J Pineal Res 2007; 43: 172-178.
57. Rodríguez-Reynoso S, Leal C, Portilla E, Olivares N, Muñiz J. Effect of exogenous melatonin on hepatic energetic status during ischemia/reperfusion: possible role of tumor necrosis factor-alpha and nitric oxide. J Surg Res 2001; 100: 141-149.
58. Presman DM, Hoijman E, Ceballos NR, Galigniana MD, Pecci A. Melatonin inhibits glucocorticoid receptor nuclear translocation in mouse thymocytes. Endocrinology 2006; 147: 5452-5459.